03 March 2022
13:00 CET

17th Clinical Trials

Innovation Programme

About Clinical Trials Innovation Programme 2022





Join us in March 2022 to learn from the best in the drug development industry and have an opportunity to learn from their experiences.

With an agenda covering the future of Clinical trials and drug development post COVID, Clinical Trials Innovation Programme 2022 will feature tailored sessions presented by the leading experts from across the globe.

We are bringing together the best in the industry to help you learn and grow, and accelerate your drug development journey.

Clinical Trials Innovation Programme Highlights!

THE TRIALS OF THE FUTURE

BOOSTING TRIAL DIVERSITY

USE OF RWD & E

CLINICAL TRIALS SUPPLY CHAIN

PAVING THE WAY FOR DIGITALIZATION

PATIENT ENROLLMENT & RETENTION



-->
0

Discussion Topics

0

Speakers

0

Attendees

0

Networking Hours

Conference Chairs



Antonella

Antonella Cardone

Former Director

European Cancer Patient Coalition

Werner

Werner Gladdines, MSc

VP, Clinical Development Operations

Immunic Therapeutics

John Doe

Gunilla Andrew-Nielsen

Head of Clinical Trials

Medical Products Agency

Experts Panel 2022

Meet our professonals



Davy Yeung

Managing Director & VP of Operations

TCRS

Kimberley Kallsen

Head of Global Clinical Development & Operations Patient & Site Engagement

Boehringer Ingelheim

Tim Davis

Vice President of Strategy, MyVeeva for Patients

Veeva Systems

Antonella Cardone

Former Director

European Cancer Patient Coalition

Giacomo

Giacomo Ricca

Lead Data Processing Solutions

The Janssen Pharmaceutical Companies of Johnson & Johnson

Frederik

Frederik Grell Nørgaard

Special Adviser

Danish Medicines Agency

Thaibaud

Thibaud Guymard

General Manager, Digital Measurement Solutions

Biogen

John Doe

Gunilla Andrew-Nielsen

Head of Clinical Trials

Medical Products Agency

John Doe

Domenico Merante

Global Clinical Development TA Lead Nephrology and Orphan Disease Area

Vifor Pharma

John Doe

Bhupathy Alagiriswamy

Clinical Trial Management | Artificial Intelligence | AI Speaker

Boehringer Ingelheim

Biocair

Lydia Bartkova

Senior Operation Data Manager

MorphoSys AG

Alexandra Babarina

Principal Data Manager

MorphoSys AG

Adar Shani

VP Clinical and Regulation

GrayMatters Health

Who Will Attend

Delegates Will Include VPs, Global Heads, Directors and Managers.



Clinical Operations
Clinical Trials
Operational Excellence
Oncology Trials
Risk Based Monitoring
Clinical Project
Clinical Trials Outsourcing
Clinical Country Leads
Medical Affairs
Clinical Oversight
Clinical R&D
Budgeting and Outsourcing
Site Feasibility
Regulatory Affairs
Innovation
Digital Therapeutics
Clinical Informatics
Clinical Data
Clinical Development
TESTIMONIALS

what people say


I would Definitely recommend this event; it is very informational and I very much enjoyed my visit here.

Acc Manager Ara Research
I’ve already communicated to my colleagues about the upcoming CTIP. I will recommend you give it a try, if you have never been to one of their conferences

Sr. Director, eClinical Solutions Intrinsic Clinical Systems
The event was very interesting. I am very impressed by the high level of the speakers. The event was also well organized in all the aspects.

Clinical Development Senior Manager Dompe farmaceutici spa

Book your seat online

Get yours why they are still available

Hot!
Global Marketing
£799



  • Inclusion of company logo and profile in welcome pack
  • Global marketing and branding for lead generation purpose



Buy Now

Hot!
Physical Pass
£1,999
  • 01 Attendee Pass
  • Access to the Conference for Two Days
  • Networking Lunch and Coffee Seats
  • Networking Drink Reception Seat
  • Hard Copy of Attendee Welcome Pack
  • Inclusion of company and personal profile in welcome pack
  • Global marketing and branding for lead generation purpose
Buy Now

Our Partners

We have Partners not Sponsors



Media Partners

Media Partners with us



Event Schedule

Have a look at Schedule

03 March 2022

13:00
Registration
13:10
Welcome from World BI
13:15
Chairperson Welcome Address
  • Antonella Cardone; Former Director, European Cancer Patient Coalition
  • Werner Gladdines, MSc; VP, Clinical Development Operations, Immunic Therapeutics
  • Gunilla Andrew-Nielsen; Head of Clinical Trials, Medical Products Agency
13:20
Keynote Presentation

Regulatory Experience from Advice and Assessment of Decentralised Clinical Trial Applications
Gunilla Andrew-Nielsen; Head of Clinical Trials, Medical Products Agency

13:45
Keynote Presentation

Digitizing Clinical Trials – Implementing Strategies to Support Patients, Sites, and Sponsors
Tim Davis; Vice President of Strategy, MyVeeva for Patients, Veeva

14:10
Keynote Presentation

Clinical Trials Innovation - AI and Decentralized Trials are the Pillars
Bhupathy Alagiriswamy; Clinical Trial Management | Artificial Intelligence | AI Speaker, Boehringer Ingelheim

14:35
Keynote Presentation

Pre and Post COIVD – what has changed in the clinical research landscape?
Davy Yeung; Managing Director & VP of Operations, TCRS

15:00
Keynote Presentation

Development of the Regulatory Framework for Decentralised Clinical Trials
Frederik Grell Nørgaard; Special Adviser, Danish Medicines Agency

15:25
Interactive Panel

Clinical Trials Post COVID-19: What the Clinical Trials will Look Like in 2022 and Beyond

  • Telehealth at the Core of Clinical Trials
  • Decentralized and Hybrid Trials on the Rise
  • Flexible and Adaptable Informed Consent and Patient Compacts
  • Executable Study Protocols
  • Moderator:

  • Antonella Cardone; Former Director, European Cancer Patient Coalition

Panelists:

  • Frederik Grell Nørgaard; Special Adviser, Danish Medicines Agency
  • Gunilla Andrew-Nielsen; Head of Clinical Trials, Medical Products Agency
  • Adar Shani; VP Clinical and Regulation, GrayMatters Health
  • Lydia Bartkova; Senior Operation Data Manager, MorphoSys AG
  • Alexandra Babarina; Principal Data Manager, MorphoSys AG
16:05
Keynote Presentation

Novel Data Streams – biosensors data in clinical trials
Giacomo Ricca; Lead Data Processing Solutions, The Janssen Pharmaceutical Companies of Johnson & Johnson

16:30
Keynote Presentation

Putting the Patient First: The Significant Role of Clinical Trials Patient Engagement in the Coming Years and Insights Generation
Kimberley Kallsen; Head of Global Clinical Development & Operations Patient & Site Engagement, Boehringer Ingelheim

16:55
Keynote Presentation

Digital Endpoints: The Use of Innovative Technologies to Improve Clinical Trials
Thibaud Guymard; General Manager, Digital Measurement Solutions, Biogen Digital Health, Biogen

17:20
Keynote Presentation

Challenges and opportunities to conduct clinical studies in ANCA-Associated vasculitis, a rare and life-threatening disease, during and after Covid-19 pandemic’

  • ANCA-Associated Vasculitis: disease overview (AAV)
  • Patients clinical characteristics of GPA and MPA
  • Novel potential therapeutic targets
  • Patients perspectives regarding this condition

Domenico Merante; Global Clinical Development TA Lead Nephrology and Orphan Disease Area, Vifor Pharma

17:45
Keynote Presentation

The Importance of Patient Involvement in Clinical Trials and Drug Development
Antonella Cardone; Former Director, European Cancer Patient Coalition

18:10
End of Conference with Closing Remarks
  • Antonella Cardone; Former Director, European Cancer Patient Coalition
  • Werner Gladdines, MSc; VP, Clinical Development Operations, Immunic Therapeutics
  • Gunilla Andrew-Nielsen; Head of Clinical Trials, Medical Products Agency
Book with us

@example.com